22–23 Jul 2026
Heidelberg Congress Center
Europe/Berlin timezone

Lymphedema Incidence and Intervention After Endometrial Cancer: Protocol for a Randomized Controlled Trial

22 Jul 2026, 12:00
1h 15m
Heidelberg Congress Center ( Heidelberg Congress Center )

Heidelberg Congress Center

Heidelberg Congress Center

Czernyring 20 69115 Heidelberg Germany
1 - Scientific Poster Poster Session

Speaker

Tormod Nilsen (The Norwegian School of Sport Sciences, Norway)

Description

Background: Our research shows that symptoms of lower-extremity lymphedema are commonly reported in women who have undergone surgery for endometrial cancer. Although previous trials have demonstrated beneficial effects of exercise training on lymphedema among women with breast cancer, the feasibility and efficacy to treat lower-extremity lymphedema in women with gynecological cancer remains unclear. Therefore, we aim to investigate the validity of self-reported lymphedema and the effects of exercise in women with endometrial cancer.
Patients and Methods: The current study is based on the cross-sectional SENSOR study, which comprises >1000 women who have undergone surgery for endometrial cancer:
First, we aim to validate the Lower Extremity Lymphedema Screening Questionnaire (LELSQ), by inviting women with self-reported lymphedema from the SENSOR study to undergo clinical and objective assessments of lymphedema. Objectively evaluation of lower-extremity lymphedema will be measured by circumferential measurements at predefined anatomical landmarks and perform bioelectric impedance analysis (BIS).
Second, we will invite 80 women with objectively confirmed lower-extremity lymphedema to participate in a randomized controlled trial comparing the effects of adding twice-weekly combined aerobic and resistance training and daily home-based exercises to promote lower-limb circulation to standard care (exercise group), with standard care alone (control group) for 20 weeks. The primary outcome will be the change in lymphedema volume, measured with BIS before and after the intervention. Secondary outcomes include lymphedema symptoms, quality of life, and physical fitness (cardiorespiratory fitness and muscle strength).
Implications for Exercise Oncology: Our research could identify LELSQ cutoff values that help detect women with early-onset lymphedema symptoms in clinical settings and guide future exercise recommendations for patients with lower-extremity lymphedema.

Keywords

Lymphedema; Endometrial Cancer; Exercise; Quality of Life

Abstract submitters declaration yes
Conflict of Interest & Ethical Approval yes

Author

Tormod Nilsen (The Norwegian School of Sport Sciences, Norway)

Co-authors

Dr Sara Hassing Johansen (The Norwegian School of Sport Sciences) Dr Lene Thorsen (Oslo University Hospital, Norway) Prof. Anne Cathrine Staff (Oslo University Hospital/ University of Oslo, Norway) Prof. Emily Burger (University of Oslo, Norway) Dr Knut Reidar Wangen (University of Oslo, Norway) Dr Pernulle Bjerre Trent (Oslo University Hospital, Norway) Dr Ane Gerda Zahl Eriksson (Oslo University Hospital, Norway)

Presentation materials

There are no materials yet.